Axsome Therapeutics (AXSM) Amortizatization of Intangibles (2015 - 2026)

Axsome Therapeutics has disclosed Amortizatization of Intangibles across 11 years of filings, most recently posting $1.6 million for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $1.6 million, up 135.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 70.08% YoY), and the FY2025 annual result was $1.3 million, down 79.62% from the prior year.
• Amortizatization of Intangibles came in at $1.6 million for Q1 2026 at Axsome Therapeutics, up from -$330000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $5.7 million in Q4 2024 to a low of -$330000.0 in Q4 2025.
• The 5-year median for Amortizatization of Intangibles is $1.6 million (2023), against an average of $1.3 million.
• Across the five-year window, Amortizatization of Intangibles surged 1154.41% in 2024 and tumbled 105.79% in 2025, its largest moves.
• Axsome Therapeutics' Amortizatization of Intangibles stood at $1.6 million in 2022, then sank by 71.75% to $454000.0 in 2023, then soared by 1154.41% to $5.7 million in 2024, then plunged by 105.79% to -$330000.0 in 2025, then surged by 576.36% to $1.6 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.6 million (Q1 2026), -$330000.0 (Q4 2025), and $684000.0 (Q3 2025), per Business Quant data.